Swiss drugmaker Novartis is planning to spend $23 billion at 10 of its U.S. facilities — including one in Millburn — as the ...

On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the ...

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...

Major” tariffs on pharmaceutical imports are coming soon, President Donald Trump says, pledging that they’d help bring drug ...

President Donald Trump said Tuesday that pharmaceutical imports will soon be hit with “major” tariffs as part of his efforts ...

“Building a pharmaceutical manufacturing plant is a four- or five-year undertaking,” he said. “And so, in the meantime, until you have that capacity, the tariff is just increasing the risk ...

“The pharmaceutical companies are going to ... found room to make an additional 30 billion doses at generic manufacturing plants in the United States. Still, there are steep obstacles to ...

Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on ...

Ashland Inc. ASH has completed a $10 million expansion of its pharmaceutical manufacturing plant in Cabreuva, Brazil. The investment considerably increases Ashland's pharmaceutical footprint and ...

President Trump wants to bring pharmaceutical manufacturing back to the U.S. Experts warn tariffs could result in shortages ...